Since treatment with phorbol 12-myristate 13-acetate (PMA) stimulated the PHLDA1 expression in human T-cells [16,17], we investigated whether PMA treatment could reverse PHLDA1 downregulation in drug-resistant breast cancer cells. Here, PHLDA1 is linked to breast carcinoma.